查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲快速檢測試劑盒市場預測至 2030 年 - 區域分析 - 按類型、產品、技術、應用和最終用戶
市場調查報告書
商品編碼
1562202

歐洲快速檢測試劑盒市場預測至 2030 年 - 區域分析 - 按類型、產品、技術、應用和最終用戶

Europe Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 172 Pages | 訂單完成後即時交付

價格

2022年歐洲快速檢測試劑盒市值為52.4446億美元，預計2030年將達到77.6357億美元；預計2022年至2030年複合年成長率為5.0%。

製造商的策略性舉措推動歐洲快速檢測試劑盒市場

快速檢測試劑盒市場的製造商強調採用創新、產品發布和批准等策略來維持市場競爭優勢。快速檢測試劑盒市場企業的此類策略舉措有利於整個市場。

2022 年，亞洲女性和胎兒健康領域的先驅、總部位於新加坡的診斷製造商 INEX Innovate 的卵巢癌旗艦解決方案 OvaCis 快速檢測獲得了 CE 標誌。到 2022 年底，OvaCis 是一種首創的床邊 (POCT) 測試，可在手術室環境中區分良性和惡性卵巢囊腫，預計將在歐盟和東南亞首次亮相市場。

2022 年 1 月，全球領先的即時護理和家庭診斷測試以及樣本採集技術領域的 OraSure Technologies, Inc. 推出了 OraQuick HIV 自檢，這是一種基於口腔拭子的 HIV 家庭測試。 ，面向歐洲市場。該測試可在六個歐洲國家進行：英國、法國、德國、義大利、西班牙和葡萄牙。

2021年，隨著CE證書的頒發，FUJIFILM Europe GmbH被授權申請CE標誌，並推出用於診斷SARS-CoV-2感染的抗原檢測試劑盒。富士膠片使用的技術稱為專有銀放大免疫色譜法，它基於用於放大待沖洗照片的相同技術。

2020 年 12 月，美國食品藥物管理局 (FDA) 發布了虛擬引導 BinaxNOW COVID-19 Ag 卡（由 Abbott 生產）快速檢測的緊急使用授權 (EUA)，適用於家庭使用來檢測新冠病毒 - 19. BinaxNOW 是一種分佈廣泛且最實惠的快速測試之一，可在幾分鐘內提供結果。

2020 年 7 月，FDA 授予緊急使用授權 (EUA)，用於快速、照護端 SARS-CoV-2 診斷測試，與其廣泛使用的 BD Veritor Plus 系統一起使用。新的檢測方法可在易於使用、高度便攜的儀器上 15 分鐘內產生結果。該測試旨在透過提供即時結果並幫助患者在測試設施中時快速做出決策，從而改善對 COVID-19 診斷的獲取。

歐洲快速檢測試劑盒市場概況

德國的糖尿病盛行率正在顯著增加。根據國際糖尿病聯盟的數據，2021 年約有 6,200 萬人患有糖尿病。此外，根據歐洲疾病預防控制中心的報告，2019年歐盟（EU）登記了8,641例瘧疾病例，其中確診8,638例（>99%）。 2022年9月，德國與聯合國愛滋病規劃署（UNAIDS）簽署了價值13.4億美元的協議，旨在對抗愛滋病、結核病和瘧疾；由此，該國的捐款比 2019 年增加了 30%。控制和消除瘧疾的資金總額為33億美元，其中德國提供2億美元。因此，隨著糖尿病、愛滋病、結核病和瘧疾等傳染病等傳染病率的上升，未來幾年德國的快速檢測試劑盒市場可能會成長。

歐洲快速檢測試劑盒市場收入及 2030 年預測（百萬美元）

歐洲快速檢測試劑盒市場細分

歐洲快速檢測試劑盒市場根據類型、產品、技術、應用、最終用戶和國家進行細分。根據類型，歐洲快速檢測試劑盒市場分為快速抗原檢測、快速抗體檢測等。 2022 年，快速抗原檢測領域佔據最大的市場。

從產品來看，歐洲快速檢測試劑盒市場分為非處方快速檢測試劑盒和專業快速檢測試劑盒。非處方快速檢測試劑盒細分市場在 2022 年佔據更大的市場。

依技術分類，歐洲快速檢測試劑盒市場分為側流檢測、固相檢測、凝集檢測、免疫斑點檢測和基於細胞組成的檢測。 2022 年，側流分析領域佔據最大的市場佔有率。

根據應用，歐洲快速檢測試劑盒市場分為血糖檢測、傳染病檢測、懷孕及生育、心臟代謝檢測等。 2022年，血糖檢測領域佔據最大的市場佔有率。

就最終用戶而言，歐洲快速檢測試劑盒市場分為醫院和診所、家庭護理、診斷中心等。 2022 年，醫院和診所領域佔據最大的市場。

根據國家/地區，歐洲快速檢測試劑盒市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022年，德國在歐洲快速檢測試劑盒市場佔有率中佔據主導地位。

F. Hoffmann-La Roche Ltd、Becton Dickinson and Co、ARKRAY Inc、Sysmex Partec GmbH、Fujirebio Europe NV、bioMerieux SA、Cepheid、Meril Life Sciences Pvt Ltd、QIAGEN NV、OraSure Technologies Inc、廣州萬孚生物科技有限公司、 Denka Co Ltd、Abbott Laboratories、Trinity Biotech Plc、Premier Medical Corp Pvt Ltd、Bio-Rad Laboratories Inc、Hologic Inc、DiaSorin SpA 和 Beckman Coulter Inc 是歐洲快速檢測試劑盒市場的一些領先參與者。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲快速檢測試劑盒市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病和傳染病的盛行率不斷上升
    • 製造商的策略舉措
  • 市場限制
    • 與結果準確性相關的不確定性
  • 市場機會
    • 對 PCR 技術的偏好不斷增加
  • 未來趨勢
    • 快速抗原檢測的創新
  • 影響分析

第 5 章：快速測試套件市場 - 歐洲市場分析

  • 概述
  • 快速測試套件市場收入，2020 - 2030

第 6 章：歐洲快速檢測試劑盒市場分析 - 按類型

  • 概述
  • 快速抗原檢測
  • 快速抗體檢測
  • 其他

第 7 章：歐洲快速檢測試劑盒市場分析 - 按產品

  • 概述
  • 非處方快速檢測試劑盒
  • 專業快速檢測試劑盒

第 8 章：歐洲快速檢測試劑盒市場分析 - 按技術

  • 概述
  • 側流層析
  • 固相
  • 凝集
  • 免疫斑點測定
  • 基於蜂窩組件

第 9 章：歐洲快速檢測試劑盒市場分析 - 按應用

  • 概述
  • 血糖測試
  • 傳染病檢測
  • 心臟代謝測試
  • 懷孕和生育
  • 其他

第 10 章：歐洲快速檢測試劑盒市場分析 - 按最終用戶

  • 概述
  • 醫院和診所
  • 診斷中心
  • 居家護理
  • 其他

第 11 章：歐洲快速檢測試劑盒市場 - 國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 12 章：產業格局

  • 概述
  • 快速檢測試劑盒市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 13 章：公司簡介

  • F. Hoffmann-La Roche Ltd
  • Becton Dickinson and Co
  • ARKRAY Inc
  • Sysmex Partec GmbH
  • Fujirebio Europe NV
  • bioMerieux SA
  • Cepheid
  • Meril Life Sciences Pvt Ltd
  • QIAGEN NV
  • OraSure Technologies Inc
  • Guangzhou Wondfo Biotech Co Ltd
  • Denka Co Ltd
  • Abbott Laboratories
  • Trinity Biotech Plc
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • DiaSorin SpA
  • Premier Medical Corp Pvt Ltd
  • Beckman Coulter Inc

第 14 章：附錄

Product Code: BMIRE00030428

The Europe rapid test kit market was valued at US$ 5,244.46 million in 2022 and is expected to reach US$ 7,763.57 million by 2030; it is estimated to record a CAGR of 5.0% from 2022 to 2030.

Strategic Initiatives by Manufacturers Drive Europe Rapid Test Kit Market

Manufacturers in the rapid test kits market emphasize on the adoption of strategies such as innovations, and product launches and approvals to maintain a competitive edge in the market. Such strategic initiatives by companies in the rapid test kits market benefit the overall market.

In 2022, Singapore-based diagnostics manufacturer INEX Innovate, a pioneer in the women's and fetal health sector in Asia, has received a CE mark for OvaCis Rapid Test, its flagship solution for ovarian cancer. By the end of 2022, OvaCis-a first-of-its-kind point-of-care (POCT) test that distinguishes benign from malignant ovarian cysts in an operating room setting-is expected to make its debut in the EU and Southeast Asian markets.

In January 2022, OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing as well as sample collection technologies, launched the OraQuick HIV Self-Test, an oral swab-based in-home test for HIV-1 and HIV-2, for the European market. The test is accessible in six European countries: the UK, France, Germany, Italy, Spain, and Portugal.

In 2021, following the issuance of the CE certificate, FUJIFILM Europe GmbH was authorized to apply the CE mark and introduce an antigen test kit for the diagnosis of SARS-CoV-2 infection. The technique being utilized by Fujifilm is called proprietary silver amplification immunochromatography, and it is based on the same technology that is used to amplify the photos to be developed.

In December 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for a virtually guided BinaxNOW COVID-19 Ag Card (by Abbott) rapid test, indicated for the at-home use for detection of COVID-19. BinaxNOW is a widely distributed and one of the most affordable rapid tests, which provides results in minutes.

In July 2020, the FDA granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The new assay generates results in 15 minutes on an easy-to-use, highly portable instrument. The test was meant to improve access to COVID-19 diagnostics by providing real-time results and aiding quick decision-making while the patient is still in the testing facility.

Europe Rapid Test Kit Market Overview

The prevalence of the diabetes in Germany has been increasing significantly. According to the International Diabetes Federation, in 2021 ~62 million people were having diabetes. Moreover, according to the European Center for Disease Prevention and Control report, 8,641 malarial cases were registered in the European Union (EU) in 2019, of which 8,638 (>99%) were confirmed diagnoses. In September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS) aiming to fight AIDS, tuberculosis, and malaria; with this, the country raised its contribution by 30% compared to 2019. Further, as per the endmalaria.org 2020 report, international sources provided 69% of total funding aiming for malaria control and elimination. The total funding for malaria control and elimination accounted for US$ 3.3 billion, including US$ 0.2 billion contributed by Germany. Thus, the rapid test kits market is likely to grow in Germany in the coming years with the rising prevalence of infectious disease such as diabetes, AIDS, tuberculosis, and malaria.

Europe Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

Europe Rapid Test Kit Market Segmentation

The Europe rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Europe rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the Europe rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the Europe rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the Europe rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the Europe rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the Europe rapid test kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Europe rapid test kit market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Rapid Test Kits Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.1.2 Strategic Initiatives by Manufacturers
  • 4.2 Market Restraints
    • 4.2.1 Uncertainties Related to Accuracy of Results
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Preference for PCR Techniques
  • 4.4 Future Trends
    • 4.4.1 Innovations in Rapid Antigen Tests
  • 4.5 Impact Analysis

5. Rapid Test Kits Market - Europe Market Analysis

  • 5.1 Overview
  • 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. Europe Rapid Test Kits Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Rapid Antigen Testing
    • 6.2.1 Overview
    • 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Rapid Antibody Testing
    • 6.3.1 Overview
    • 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Rapid Test Kits Market Analysis - by Product

  • 7.1 Overview
  • 7.2 Over-the-Counter Rapid Testing Kit
    • 7.2.1 Overview
    • 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Professional Rapid Testing Kit
    • 7.3.1 Overview
    • 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Rapid Test Kits Market Analysis - by Technology

  • 8.1 Overview
  • 8.2 Lateral Flow Assay
    • 8.2.1 Overview
    • 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Solid Phase
    • 8.3.1 Overview
    • 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Agglutination
    • 8.4.1 Overview
    • 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Immunospot Assay
    • 8.5.1 Overview
    • 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cellular-Component Based
    • 8.6.1 Overview
    • 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Rapid Test Kits Market Analysis - by Application

  • 9.1 Overview
  • 9.2 Blood Glucose Testing
    • 9.2.1 Overview
    • 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Infectious Disease Testing
    • 9.3.1 Overview
    • 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cardiometabolic Testing
    • 9.4.1 Overview
    • 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pregnancy and Fertility
    • 9.5.1 Overview
    • 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Rapid Test Kits Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospital and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Home-Care
    • 10.4.1 Overview
    • 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Rapid Test Kits Market - Country Analysis

  • 11.1 Europe
    • 11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Germany
        • 11.1.1.1.1 Overview
      • 11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.3 United Kingdom
        • 11.1.1.3.1 Overview
      • 11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.5 France
        • 11.1.1.5.1 Overview
      • 11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.7 Italy
        • 11.1.1.7.1 Overview
      • 11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.9 Spain
        • 11.1.1.9.1 Overview
      • 11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
      • 11.1.1.11 Rest of Europe
        • 11.1.1.11.1 Overview
      • 11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
        • 11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
        • 11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
        • 11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
        • 11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
        • 11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Rapid Test Kit Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 F. Hoffmann-La Roche Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Becton Dickinson and Co
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 ARKRAY Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sysmex Partec GmbH
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Fujirebio Europe NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 bioMerieux SA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Cepheid
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Meril Life Sciences Pvt Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 QIAGEN NV
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 OraSure Technologies Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Guangzhou Wondfo Biotech Co Ltd
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 Denka Co Ltd
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 Abbott Laboratories
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Trinity Biotech Plc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Bio-Rad Laboratories Inc
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 Hologic Inc
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 DiaSorin SpA
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 Premier Medical Corp Pvt Ltd
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Beckman Coulter Inc
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Rapid Test Kits Market Segmentation
  • Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 4. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 5. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 6. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 7. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 8. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 10. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 11. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 12. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 13. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 14. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 16. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 17. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 18. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 20. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 22. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 23. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 24. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 25. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 26. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 28. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 30. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 31. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 32. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 33. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 34. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 35. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
  • Table 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 37. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
  • Table 38. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
  • Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market

List Of Figures

  • Figure 1. Rapid Test Kits Market Segmentation, By Country
  • Figure 2. Rapid Test Kits Market: Key Industry Dynamics
  • Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
  • Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
  • Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
  • Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
  • Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
  • Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Growth Strategies in the Rapid Test Kit Market